SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-098239
Filing Date
2022-09-07
Accepted
2022-09-07 16:40:40
Documents
13
Period of Report
2022-09-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2225397d1_8k.htm   iXBRL 8-K 34322
2 EXHIBIT 10.1 tm2225397d1_ex10-1.htm EX-10.1 214069
  Complete submission text file 0001104659-22-098239.txt   455373

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA swtx-20220906.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE swtx-20220906_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE swtx-20220906_pre.xml EX-101.PRE 22605
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2225397d1_8k_htm.xml XML 3496
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 221231612
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences